Kretingos vaistinė - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 1,190,850 | 1,230,808 | 1,294,230 | 1,324,412 | 1,384,017 | 1,417,365 | 1,513,534 | 1,613,501 |
| Profit before tax | 68,957 | 64,028 | 71,275 | 109,948 | 82,959 | 88,779 | 82,864 | 97,940 |
| Net profit | 58,718 | 54,557 | 60,609 | 93,407 | 70,597 | 75,504 | 70,563 | 82,282 |
| Equity | 353,488 | 337,237 | 331,046 | 357,653 | 348,091 | 343,435 | 320,478 | 322,600 |
| Liabilities | 94,636 | 80,544 | 76,718 | 39,992 | 30,951 | 33,142 | 36,879 | 64,598 |
| Non-current assets | 221,382 | 113,115 | 94,169 | 73,653 | 54,364 | 55,562 | 77,047 | 55,092 |
| Current assets | 215,202 | 301,844 | 310,973 | 323,194 | 323,786 | 320,195 | 277,747 | 330,852 |
| Total assets | 436,584 | 414,959 | 405,142 | 396,847 | 378,150 | 375,757 | 354,794 | 385,944 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 87,042 | 92,821 | 99,716 |
| Social insurance contributions | - | - | - | - | - | 44,933 | 49,438 | 53,847 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +0.9% | +3.4% | +5.2% | +2.3% | +4.5% | +2.4% | +6.8% | +6.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 13.4% | 13.1% | 15.0% | 23.5% | 18.7% | 20.1% | 19.9% | 21.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 16.6% | 16.2% | 18.3% | 26.1% | 20.3% | 22.0% | 22.0% | 25.5% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 4.9% | 4.4% | 4.7% | 7.1% | 5.1% | 5.3% | 4.7% | 5.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 5.8% | 5.2% | 5.5% | 8.3% | 6.0% | 6.3% | 5.5% | 6.1% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.3 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 91,604 | 94,075 | 99,556 | 106,664 | 112,218 | 121,488 | 136,560 | 146,682 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Kretingos vaistinė - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-05-17 | 2026-05-20 | 0.01 |
Kretingos vaistinė - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Kretingos vaistine, UAB (code 164137361) is a Private Limited Liability Company engaged in the retail sale of pharmaceutical products. In 2025, the company generated revenue of €1.61M and net profit of €82.3K, with a profit margin of 5.1%. Revenue increased by 6.6% year on year and by 13.8% over two years, showing a steady upward trend. Profitability also remained positive across the period: net profit was €75.5K in 2023, €70.6K in 2024, and €82.3K in 2025. The balance sheet strengthened moderately, with total assets of €385.9K, equity of €322.6K, and liabilities of €64.6K at the end of 2025. The equity ratio stood at 83.6% and debt-to-equity at 0.20, indicating a low leverage position. Asset turnover was 4.18x, while ROE was 25.5% and ROA 21.3%. Revenue per employee reached €146.7K, and profit per employee €7.5K in 2025.